Flumetasone

Chemical formula: C₂₂H₂₈F₂O₅  Molecular mass: 410.458 g/mol  PubChem compound: 16490

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
D07AB03 Flumetasone D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AB Corticosteroids, moderately potent (group II)
Discover more medicines within D07AB03
D07XB01 Flumetasone D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations
Discover more medicines within D07XB01

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 2002-29-1
CAS Substance: 2135-17-3
DrugBank Drug: DB00663
KEGG Drug: D04208
PubChem Compound: 16490
RxNorm Ingredient: 4458
SNOMED-CT Concept: 116598007
Flumetasone (substance)
UNII Identifier: LR3CD8SX89
FLUMETHASONE

Medicines

Flumetasone is an active ingredient of these brands:

Canada (CA)

Finland (FI)

Germany (DE)

Hong Kong (HK)

  • (combination) ORSALIN as FLUMETHASONE PIVALATE

Israel (IL)

  • (combination) TOPISALEN as FLUMETHASONE PIVALATE

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.